Because in our study, the adverse prognosis of patients with elevated cTnI levels was determined on an all‐cause basis and not by readmission rates for cardiovascular causes, we consider that the performance of ischemia detection studies should be established individually, according to the pre‐test probability of ischemic heart disease and the clinical characteristics of the acute episode. The gene discussed is TNNI3; the disease is coronary artery disorder.